Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-gated sodium channels (NaV) are essential membrane proteins responsible for the initiation and propagation of action potentials. Slow inactivation is a biophysical process that regulates the availability of these channels over extended periods (seconds to minutes), influencing membrane excitability, firing properties, and spike frequency adaptation. It involves structural rearrangements at the pore and selectivity filter, contributing to slow spike adaptation and burst termination during repetitive or prolonged depolarizations. Defective slow inactivation is linked to diseases like hyperkalemic periodic paralysis and long-QT syndrome. Drugs targeting sodium channels can interact with state-dependent receptor sites, including those associated with slow-inactivated conformations, offering possibilities for improved specificity.
State-dependent binding to sodium channels, stabilizing the slow-inactivated state and reducing sodium current
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-Gated Sodium Channel (Slow Inactivation) (NaV (Slow Inactivation)).